Table 1. Lines of chemotherapy applied for treatment of the patient.
| Dates | Drug scheme | Result | |
|---|---|---|---|
| 1 | Nov 2016- Apr 2017 | Adryamicin+cyclophosphamide (x4), paclitaxel+carbloplatin (x4) | Local recurrence |
| 2 | June-Aug 2017 | Bevacizumab+capetacibine | Progression |
| 3 | Sept-Oct 2017 | Eribulin (x2) | Progression |
| 4 | Nov-Dec 2017 | Gemcitabine+cisplatinum | Progression |
| 5 | Jan-Feb 2018 | Docetaxel (x2) | Progression |
| 6 | Feb-Apr 2018 | Vinorelbin+capetacebin | Progression |
| 7 | Apr-Aug 2018 | Elenagen+cyclophosphamide+methotrexate+fluorouracil | Partial response |